Adapting to telehealth was not difficult, but practice transformation around telehealth has been more difficult, and there remains the future uncertainty around continued reimbursement, said Sibel Blau, MD, of Northwest Medical Specialties and Quality Cancer Care Alliance.
Adapting to telehealth was not difficult, but practice transformation around telehealth has been more difficult, and there remains the future uncertainty around continued reimbursement, said Sibel Blau, MD, medical oncologist, Northwest Medical Specialties, and president and CEO, Quality Cancer Care Alliance (QCCA).
Transcript
At the 2019 QCCA Fall Leadership Summit, keynote speaker Susan Dentzer had discussed better utilizing technology to move cancer care beyond the conventional walls of the health care delivery system. How have oncology practices tried make that change?
It is actually very variable from practice to practice and institution to institution. I look at what we have done with telehealth for QCCA practices, and we did share this information. I see the significant variability among using telehealth among practices.
But we have adjusted very fast when telehealth became available to practice this in the beginning of the pandemic, it was a matter of days that practices started using telehealth to take care of the patients—any kind of patient actually, at that time, not just the survivorship or chemotherapy teaching or palliative care like we use now, but any kind of patient care because we wanted to reach out to all our patients out there that were afraid to come to the clinics, and we were afraid to open them to our clinics.
So, adapting to telehealth was not a big issue. Choosing the tool, using it appropriately, developing practice transformation around telehealth had been a bigger issue for most practices. And in fact, some institutions, some big academic centers and bigger hospital systems have put a break on telehealth as they don't know, or we don't know, how this is going to move into the future as far as the payment process. So, as soon as this is more clarified, and we can standardize telehealth use, I think it's going to be evolving into an era that we don't even imagine now.
And I look at Susan Dentzer’s talk last year—we were talking about the rural areas—and she was saying every patient in this country needs the same kind of care. And if you think about going to the future, the technology is going to evolve, technology's going to adjust to this way better than the doctors and the institutions adjust to this. So, I think it's going to be an amazing future. And I really believe that.
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Managed Care Reflections: A Q&A With Melinda B. Buntin, PhD
June 2nd 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The June issue features a conversation with Melinda B. Buntin, PhD, a health economist and a Bloomberg Distinguished Professor at the Johns Hopkins Bloomberg School of Public Health and Carey Business School.
Read More
Trastuzumab Deruxtecan Plus Pertuzumab Improves PFS vs Standard Care in HER2+ Breast Cancer
June 2nd 2025Trastuzumab deruxtecan plus pertuzumab demonstrated statistically and clinically significant improvement in progression-free survival (PFS) in HER2-positive breast cancer, potentially representing a new standard of care.
Read More